Contract 36E79721D0013
Specgx Llc · Department Of Veterans Affairs · April 29, 2025
Specgx Llc was awarded a federal contract by Department Of Veterans Affairs on April 29, 2025 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on January 6, 2026. If all options are exercised, the contract could reach $28.22 million.
Contract details
- PIID
- 36E79721D0013
- Award type
- Indefinite Delivery / Requirements
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- April 29, 2025
- Latest action
- January 6, 2026
Description
THIS MODIFICATION IS ISSUED TO INCORPORATE SPECGX LLC 2026 SUBCONTRACTING PLAN EFFECTIVE FOR THE PERIOD OF JANUARY 1, 2026 -- DECEMBER 31, 2026.
Modification timeline
-
January 6, 2026Mod P00012 · Add Subcontracting Plan$0
-
April 29, 2025Mod P00011$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Covermymeds Pharmacy Llc | Department Of Veterans Affairs | July 2, 2026 | $16.4K |
| United Therapeutics Corp | Department Of Veterans Affairs | July 2, 2026 | $17.4K |
| Sk Life Science, Inc. | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Theracom, L.L.C. | Department Of Veterans Affairs | July 2, 2026 | $38.1K |
| Cycle Pharmaceuticals Ltd | Department Of Veterans Affairs | July 2, 2026 | $0 |
| Regimed Medical | Department Of Veterans Affairs | July 2, 2026 | $292.9K |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79721D0013?
Contract 36E79721D0013 is a federal contract awarded to Specgx Llc by Department Of Veterans Affairs on April 29, 2025 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 36E79721D0013?
Specgx Llc won contract 36E79721D0013 from Department Of Veterans Affairs.
How much is contract 36E79721D0013 worth?
Contract 36E79721D0013 has obligated $0 to date but carries a potential ceiling of $28.22 million if fully funded and all options are exercised.